IGF1 and neoplasm: In recent years, some large-sample cohort, Mendelian randomization, and functional studies have gradually revealed the molecular mechanisms of the IGF-I signaling axis in tumorigenesis, suggesting that it may become a potential target for tumor prevention and early screening, but there are still gaps in evidence and unclear mechanisms (1, 4, 5).